Sofinnova Investments, Inc. Spectrum Pharmaceuticals Inc Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 15, 2018	SELL	$16.52 - $24.82 $2.81 Million - $4.22 Million	-169,965 Closed	0 $0
Q2 2018 Nov 15, 2018	BUY	$14.31 - $21.75 $2.18 Million - $3.32 Million	152,477 Added 871.9%	169,965 $3.56 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $250,253 - $380,364	17,488 New	17,488 $367,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.